Compare Axogen Inc (AXGN) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Toronto-Dominion Bank — how do they compare? Axogen Inc trades at $48.35 (market cap $2.61B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 76.8× Axogen Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | TD | |
|---|---|---|
Market Cap | $2.61B | $200.48B |
Sector | Technology | Financials |
52-Week High | $48.48 | $124.80 |
52-Week Low | $14.16 | $72.85 |
Enterprise Value | $2.52B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
